Skip to main content

Carbazole

ADVERTISEMENT
Identification
Molecular formula
C12H9N
CAS number
86-74-8
IUPAC name
14,15-diazatetracyclo[7.6.1.02,7.013,16]hexadeca-1(15),2,4,6,9(16),10,12-heptaen-8-one
State
State
Carbazole is a solid at room temperature, commonly found as crystalline powder or flakes. It is stable and does not react with water.
Melting point (Celsius)
245.50
Melting point (Kelvin)
518.65
Boiling point (Celsius)
354.30
Boiling point (Kelvin)
627.45
General information
Molecular weight
167.21g/mol
Molar mass
167.2120g/mol
Density
1.2820g/cm3
Appearence
Carbazole is a white to pale yellow crystalline solid. The crystals can exhibit different shades of yellow depending on the purity and may have a faint aromatic odor. The compound's appearance as a solid makes it easily distinguishable by its crystalline form.
Comment on solubility

Solubility of 14,15-Diazatetracyclo[7.6.1.02,7.013,16]hexadeca-1(15),2,4,6,9(16),10,12-heptaen-8-one

The solubility of 14,15-diazatetracyclo[7.6.1.02,7.013,16]hexadeca-1(15),2,4,6,9(16),10,12-heptaen-8-one is an intriguing aspect that sheds light on its chemical behavior in various solvents. Understanding the solubility characteristics can help elucidate its potential applications and interactions.

Key Points on Solubility:

  • Polar vs. Non-polar Solvents: This compound may display varying degrees of solubility in polar and non-polar solvents due to its complex structure. Generally, compounds with polar functional groups tend to be more soluble in polar solvents.
  • Temperature Dependency: The solubility of many organic compounds can increase with temperature. Hence, studying this compound's solubility at different temperatures can provide valuable insights.
  • Structural Considerations: The presence of multiple rings and nitrogen atoms can influence the intermolecular interactions, potentially affecting how well it dissolves in various media.

It is essential to experimentally determine the solubility of this compound in different solvents for practical applications. As the saying goes, “Solubility is a window into molecular interactions.”
This understanding could lead to advancements in areas such as pharmaceuticals, where solubility plays a critical role in drug efficacy and delivery.

Interesting facts

Interesting Facts about 14,15-Diazatetracyclo[7.6.1.02,7.013,16]hexadeca-1(15),2,4,6,9(16),10,12-heptaen-8-one

This fascinating compound, with a complex structure, boasts significant implications in various fields of chemistry and biology.

Unique Structural Features

  • Multi-cyclic Structure: The compound features a unique tetracyclic backbone that allows for intriguing interactions and reactivity.
  • Diazine Functions: The presence of nitrogen atoms in its structure contributes to its distinctive chemical properties, which can be exploited in numerous reactions.
  • Conjugated System: The conjugated system within the compound aids in its electronic properties, potentially influencing light absorption and photophysical behavior.

Biological Significance

The compound's complex nature suggests potential biological activities. Many nitrogen-containing heterocycles are vital in pharmaceutical chemistry and have led to the development of various medications. Research has indicated that such structures can exhibit:

  • Antimicrobial Properties: Certain related compounds have shown effectiveness against bacterial infections.
  • Cytotoxic Effects: Some analogs demonstrate the ability to inhibit cancer cell proliferation.
  • Neuroprotective Activities: Compounds that incorporate nitrogen often display protective effects on neuronal cells.

Applications in Research

In the realm of synthetic and medicinal chemistry, compounds like this one are valuable for:

  • Designing novel therapeutic agents that can address antibiotic resistance.
  • Exploring new materials with unique electronic properties for use in organic electronics.
  • Studying the fundamental aspects of organic synthesis and reaction mechanisms.

The complexity and potential of 14,15-diazatetracyclo[7.6.1.02,7.013,16]hexadeca-1(15),2,4,6,9(16),10,12-heptaen-8-one make it an intriguing subject for ongoing research and discovery in the fields of chemistry and biology.

Synonyms
129-56-6
1,9-Pyrazoloanthrone
SP600125
Pyrazolanthrone
Dibenzo[cd,g]indazol-6(2H)-one
Pyrazoleanthrone
SP 600125
Anthra[1,9-cd]pyrazol-6(2H)-one
SP-600125
JNK Inhibitor II
ANTHRA(1,9-cd)PYRAZOL-6(2H)-ONE
C.I. 70300
2H-Dibenzo[cd,g]indazol-6-one
NSC 75890
NSC75890
EINECS 204-955-6
NSC-75890
BRN 0746890
2h-dibenzo(cd,g)indazol-6-one
DTXSID2040525
UNII-1TW30Y2766
CHEBI:90695
MFCD00022289
1TW30Y2766
CHEMBL7064
CI 70300
MLS002693964
Anthra-1,9-pyrazol-6-none
DTXCID0020525
14,15-diazatetracyclo[7.6.1.02,7.013,16]hexadeca-1(15),2,4,6,9(16),10,12-heptaen-8-one
NCGC00015958-03
dibenzo(cd,g)indazol-6(2H)-one
14,15-diazatetracyclo[7.6.1.0^{2,7}.0^{13,16}]hexadeca-1(15),2(7),3,5,9,11,13(16)-heptaen-8-one
SMR000015440
SR-01000075840
1pmv
2zmd
14,15-diazatetracyclo(7.6.1.0^(2,7).0^(13,16))hexadeca-1(15),2(7),3,5,9,11,13(16)-heptaen-8-one
Kinome_3844
Tocris-1496
BiomolKI_000068
Lopac-S-5567
BiomolKI2_000072
cid_8515
CBiol_002049
Lopac0_000473
BMK1-G8
BSPBio_001066
ChemBiol10705 Compound 4
KBioGR_000406
KBioSS_000406
JMC517015 Compound 2
MLS002153267
MLS006011577
SCHEMBL170980
anthra[1,9-cd]pyrazol-6-one
GTPL5273
Pyrazolanthrone (SP600125)
CHEMBL1725279
SCHEMBL15583517
BCBcMAP01_000053
BDBM16018
dibenz[cd,g]indazol-6(2h)-one
KBio2_000406
KBio2_002974
KBio2_005542
KBio3_000771
KBio3_000772
Bio1_000335
Bio1_000824
Bio1_001313
Bio2_000373
Bio2_000853
GLXC-03091
HMS1362F07
HMS1667K13
HMS1792F07
HMS1990F07
HMS2250C03
HMS3229I16
HMS3261O08
HMS3267P06
HMS3295M01
HMS3403F07
HMS3412F05
HMS3654P10
HMS3676F05
HMS3747M19
PS653
ALBB-024051
Anthra[1,9cd]pyrazol-6(2H)-one
BCP05457
EX-A1998
Tox21_110267
Tox21_500473
Anthra[1-9-cd]pyrazol-6(2H)-one
BDBM50024294
BDBM50433916
CCG-47500
Dibenzo[cd,g]indazol-6(2H)-one #
HB2234
HSCI1_000136
NSC755773
s1460
AKOS000115584
AKOS040751313
Anthrapyrazolone; 1,9-Pyrazoloanthrone
CCG-100672
CS-0196
DB01782
FP33726
LP00473
NSC-755773
SDCCGSBI-0050458.P003
SDCCGSBI-0050458.P009
WLN: T C66651A P IV OMNJ
1,6-dihydrodibenzo[cd,g]indazol-6-one
2,6-dihydrodibenzo[cd,g]indazol-6-one
IDI1_002128
QTL1_000077
s10332
SMP2_000240
NCGC00015958-01
NCGC00015958-02
NCGC00015958-04
NCGC00015958-05
NCGC00015958-06
NCGC00015958-07
NCGC00015958-08
NCGC00015958-22
NCGC00025186-01
NCGC00025186-02
NCGC00025186-03
NCGC00025186-04
NCGC00025186-05
NCGC00261158-01
WLN: T C6665 1A P IV OMNJ
AC-32051
AS-14374
CAS-129-56-6
HY-12041
JNK Inhibitor II - CAS 129-56-6
SMR002530644
SY052909
DB-041928
SP600125?
A2548
EU-0100473
NS00020981
SW218106-2
EN300-02083
Anthra[1,9-cd]pyrazol-6(2H)-one & Z-100
K00068
S 5567
SP600125, >=98% (HPLC)
AB00075935-01
SP 600125 & Z-100
AE-641/00620033
Q4545713
SR-01000075840-1
SR-01000075840-2
SR-01000075840-4
SR-01000075840-6
SR-01000637108-1
BRD-K01567962-001-04-0
BRD-K01567962-001-06-5
BRD-K01567962-001-08-1
BRD-K01567962-001-22-2
BRD-K01567962-001-23-0
BRD-K01567962-001-24-8
Z56785477
F1414-1245
14,15-diazatetracyclo[7.6.1.0;{2,7}.0;{13,16}]hexadeca-1(15),2(7),3,5,9(16),10,12-heptaen-8-one
14,15-diazatetracyclo[7.6.1.0^{2,7}.0^{13,16}]hexadeca-1(15),2,4,6,9(16),10,12-heptaen-8-one